AddLife AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0014401378
SEK
136.80
0.4 (0.29%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 17.75

 
2

Healthy long term growth as Net Sales has grown by an annual rate of 14.64% and Operating profit at 3.77%

 
3

With a growth in Net Profit of 220.99%, the company declared Outstanding results in Dec 25

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 17,057 Million (Small Cap)

stock-summary
P/E

62.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.52%

stock-summary
Debt Equity

0.73

stock-summary
Return on Equity

10.49%

stock-summary
Price to Book

3.13

Revenue and Profits:
Net Sales:
2,733 Million
(Quarterly Results - Dec 2025)
Net Profit:
260 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.71%
0%
-15.71%
6 Months
-24.25%
0%
-24.25%
1 Year
-7.13%
0%
-7.13%
2 Years
23.58%
0%
23.58%
3 Years
52.17%
0%
52.17%
4 Years
-45.28%
0%
-45.28%
5 Years
-13.53%
0%
-13.53%

AddLife AB for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
14.64%
EBIT Growth (5y)
3.77%
EBIT to Interest (avg)
17.75
Debt to EBITDA (avg)
2.74
Net Debt to Equity (avg)
0.86
Sales to Capital Employed (avg)
0.98
Tax Ratio
34.80%
Dividend Payout Ratio
32.64%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.70%
ROE (avg)
13.77%

Valuation key factors

Factor
Value
P/E Ratio
62
Industry P/E
Price to Book Value
4.16
EV to EBIT
34.47
EV to EBITDA
16.78
EV to Capital Employed
2.66
EV to Sales
2.56
PEG Ratio
0.94
Dividend Yield
0.40%
ROCE (Latest)
7.71%
ROE (Latest)
6.69%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 12.52% vs -5.78% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 217.07% vs -18.00% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,733.00",
          "val2": "2,429.00",
          "chgp": "12.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "410.00",
          "val2": "359.00",
          "chgp": "14.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "50.00",
          "val2": "54.00",
          "chgp": "-7.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "260.00",
          "val2": "82.00",
          "chgp": "217.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "73.50%",
          "val2": "65.90%",
          "chgp": "0.76%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 1.52% vs 6.21% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 121.26% vs 32.29% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10,442.00",
          "val2": "10,286.00",
          "chgp": "1.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,589.00",
          "val2": "1,532.00",
          "chgp": "3.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "221.00",
          "val2": "319.00",
          "chgp": "-30.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-10.00",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "562.00",
          "val2": "254.00",
          "chgp": "121.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "74.70%",
          "val2": "70.00%",
          "chgp": "0.47%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
2,733.00
2,429.00
12.52%
Operating Profit (PBDIT) excl Other Income
410.00
359.00
14.21%
Interest
50.00
54.00
-7.41%
Exceptional Items
0.00
0.00
Consolidate Net Profit
260.00
82.00
217.07%
Operating Profit Margin (Excl OI)
73.50%
65.90%
0.76%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 12.52% vs -5.78% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 217.07% vs -18.00% in Sep 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
10,442.00
10,286.00
1.52%
Operating Profit (PBDIT) excl Other Income
1,589.00
1,532.00
3.72%
Interest
221.00
319.00
-30.72%
Exceptional Items
0.00
-10.00
100.00%
Consolidate Net Profit
562.00
254.00
121.26%
Operating Profit Margin (Excl OI)
74.70%
70.00%
0.47%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 1.52% vs 6.21% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 121.26% vs 32.29% in Dec 2024

stock-summaryCompany CV
About AddLife AB stock-summary
stock-summary
AddLife AB
Pharmaceuticals & Biotechnology
AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
Company Coordinates stock-summary
Company Details
Brunkebergstorg 5, Box 3145 , STOCKHOLM None : 103 62
stock-summary
Tel: 46 8 4200383046 70 5101223
stock-summary
Registrar Details